Genprex, Inc.
GNPX
$2.83
$0.093.29%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -47.17% | 52.68% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -28.53% | 17.95% | |||
| Operating Income | 28.53% | -17.95% | |||
| Income Before Tax | 18.73% | -17.92% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 18.73% | -17.92% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 18.73% | -17.92% | |||
| EBIT | 28.53% | -17.95% | |||
| EBITDA | 28.54% | -17.96% | |||
| EPS Basic | 41.03% | 34.77% | |||
| Normalized Basic EPS | 41.03% | 34.77% | |||
| EPS Diluted | 41.03% | 34.77% | |||
| Normalized Diluted EPS | 41.03% | 34.77% | |||
| Average Basic Shares Outstanding | 37.80% | 80.77% | |||
| Average Diluted Shares Outstanding | 37.80% | 80.77% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||